Evidence map›Paper›PMID 39267935›Full record

ArticleIranian journal of microbiology2024

Evaluating the frequency and risk factors of multidrug-resistant bacteria in biliary samples.

Mehmet Yildiz, Merve Buyukkoruk, Seyma Arslan, Ulas Gokalp, Hasan Bostanci, Kursat Dikmen, Cagri Buyukkasap, Hasan Selcuk Ozger, Murat Dizbay

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Iranian journal of microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mehmet YildizDepartment of Infectious Disease and Clinical Microbiology, School of Medicine, Gazi University, Ankara, Türkiye.
Merve BuyukkorukDepartment of Infectious Disease and Clinical Microbiology, School of Medicine, Gazi University, Ankara, Türkiye.
Seyma ArslanDepartment of Infectious Disease and Clinical Microbiology, School of Medicine, Gazi University, Ankara, Türkiye.
Ulas GokalpDepartment of Infectious Disease and Clinical Microbiology, School of Medicine, Gazi University, Ankara, Türkiye.
Hasan BostanciDepartment of General Surgery, School of Medicine, Gazi University, Ankara, Türkiye.
Kursat DikmenDepartment of General Surgery, School of Medicine, Gazi University, Ankara, Türkiye.
Cagri BuyukkasapDepartment of General Surgery, School of Medicine, Gazi University, Ankara, Türkiye.
Hasan Selcuk OzgerDepartment of Infectious Disease and Clinical Microbiology, School of Medicine, Gazi University, Ankara, Türkiye.
Murat DizbayDepartment of Infectious Disease and Clinical Microbiology, School of Medicine, Gazi University, Ankara, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: This study aimed to evaluate the frequency of multidrug-resistant (MDR) bacteria in biliary samples, MDR-bacteria risk factors, and the relationship between MDR-bacteria positivity and some clinical outcomes. Materials and Methods: The study was conducted between May 2018 and May 2023, including patients over the age of 18 who had positive culture results in biliary samples. The frequency of MDR-bacteria in biliary samples was evaluated. Risk factors for MDR bacteria were assessed using univariate and multivariate analyses. MDR and non-MDR groups were compared inappropriate empirical antibiotic treatment, total antibiotic treatment duration, length of stay, and in-hospital mortality. Results: 342 microorganisms were isolated from 202 patients. Conclusion: MDR-bacteria positivity is associated with inappropriate antibiotic treatment, prolonged hospitalization, and increased mortality. Screening, antibiotic prophylaxis, and empirical treatment approaches should be carefully performed in patients with malignancy and recent antibiotic use, which are significant risk factors for MDR-bacteria.

Indexed as

Antibiotic prophylaxisAntimicrobial stewardshipBiliary tractColorectal surgeryDrug resistanceGastrointestinal neoplasmsMicrobial

Identifiers

PMID39267935
PMCPMC11389767

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.